LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 868 | 1376 | 3440 | 0.4000 | 0.2609 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 1 | L19 | 72 | hr | 868 | 1192 | 3286 | 0.3627 | 0.1795 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 868 | 1434 | 3505 | 0.4091 | 0.2831 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 868 | 1463 | 3440 | 0.4253 | 0.3005 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 868 | 3141 | 3429 | 0.9158 | 0.9132 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 868 | 3298 | 3652 | 0.9031 | 0.9040 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 868 | 3274 | 3587 | 0.9127 | 0.9127 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 868 | 2589 | 3429 | 0.7549 | 0.7355 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 868 | 2495 | 3652 | 0.6832 | 0.6642 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 868 | 2475 | 3587 | 0.6899 | 0.6683 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 868 | 1895 | 3429 | 0.5525 | 0.4827 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 868 | 2110 | 3652 | 0.5778 | 0.5349 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 868 | 1917 | 3587 | 0.5344 | 0.4726 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 868 | 1755 | 3429 | 0.5117 | 0.4264 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 868 | 1888 | 3652 | 0.5170 | 0.4548 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 868 | 1795 | 3587 | 0.5004 | 0.4260 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 868 | 1610 | 3429 | 0.4694 | 0.3656 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 868 | 1705 | 3652 | 0.4669 | 0.3849 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 868 | 1709 | 3587 | 0.4764 | 0.3922 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 868 | 1447 | 3429 | 0.4219 | 0.2940 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 868 | 1474 | 3652 | 0.4036 | 0.2910 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 868 | 1480 | 3587 | 0.4126 | 0.2977 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 1 | F06 | 72 | hr | 868 | 3273 | 3429 | 0.9543 | 0.9533 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 2 | F06 | 72 | hr | 868 | 3572 | 3652 | 0.9781 | 0.9787 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 3 | F06 | 72 | hr | 868 | 3619 | 3587 | 1.0088 | 1.0086 |